Bettina Thumm
CEO
Citus
Citus develops the NIMBLEeva, a non-invasive skin characterization tool that utilizes advanced mechanical assessment techniques to measure skin stiffness with high sensitivity and accuracy. This technology addresses the need for objective evaluations of skin health, particularly in challenging anatomical locations and diverse material types.
- Hardware
- Healthcare Technology
- Medical Devices
Updated 23 months ago
Funding
Raised to date
$420KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for evaluating skin health often lack objective measures, especially in anatomically challenging areas or when dealing with diverse skin types. This limitation hinders the ability to accurately assess skin conditions and track the effectiveness of treatments.
Solution
Citus develops the NIMBLEeva, a non-invasive skin characterization tool that utilizes advanced mechanical assessment techniques to objectively measure skin stiffness with high sensitivity and accuracy. The device provides data-driven insights into skin structure and mechanics, enabling personalized skin care approaches. NIMBLEeva allows for the objective assessment of skin, addressing the need for more precise and reliable evaluations of skin health.
Target Audience
The primary target audience includes skincare professionals, dermatologists, and researchers seeking objective and reliable tools for assessing skin health and developing personalized treatment plans.
Features
- Non-invasive measurement of skin stiffness using advanced mechanical assessment techniques.
- High sensitivity and accuracy in characterizing skin properties.
- Objective evaluation of skin health in challenging anatomical locations.
- Data-driven technology for personalized skin care.